News
On Monday, nine-session winning streaks ended for both the S&P 500 and Dow Jones Industrial Average.These stocks were poised ...
Hims & Hers Health (NYSE:HIMS) stock spikes, risking a short squeeze given its elevated short interest. Read more here.
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Shares of Hims & Hers Health ( HIMS -5.48%) and LifeMD ( LFMD -14.33%) are surging on Tuesday. The companie' stocks had ...
Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on ...
6don MSN
Shares in Hims & Hers Health soared in early-morning trading after it announced a partnership with Wegovy maker Novo Nordisk.
Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with ...
The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback